India achieves major milestones in the fight against malaria, kala-azar, and filariasis in 2024, meeting key targets for ...

Two deaths from Nipah virus, a zoonotic pathogen with a high mortality rate, were reported in Kerala, India in June and ...

The National Vector Borne Disease Control Programme (NVBDCP) is responsible for preventing and controlling these diseases.

At the ETHealthworld NutriWell Conclave, for overcoming the heightened disease burden in the country key experts and ...

Half of the world's population is living in areas where dengue fever is present. Asian countries are most affected, reporting ...

In the trading parlance that our stock-market-hooked city prefers, chikungunya emerged as the highest gainer in the major ...

There has been a significant rise in fake news and deepfake concerns in India, revealed a study on Friday ... showed that ...

BRICS, India-US civil nuclear deal, Quad, Pakistan, SCO, were all part of late former PM's foreign engagements, which set ...

India is currently the fifth-largest market for Apple, while Japan is the third-largest country and the UK the fourth. India’s climb up the revenue and sales leaderboards for Apple, experts believe, ...

The country aims to achieve zero indigenous cases by 2027. According to the Centre, malaria cases and deaths have dropped by ...

New Delhi [India], December 3: Vector Consulting Group, one of India's leading home-grown management consulting company has recently recruited 21 interns from the top B-schools of the country. The ...

Serum Institute of India will manufacture Valneva's anti-Chikungunya vaccine for India and select Asian markets, addressing a major public health issue.